GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Millennium Pharmacon International Tbk PT SDPC.JK · IDR

Health Care · IDX · 🇮🇩 Indonesia

Compare

180

-1.64%

Close of 9 Nov 2026, in IDR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in IDR, from our data supplier.

FY2025

Revenue

IDR 4.11trn

FY2016FY2025

Net income

IDR 38.47bn

FY2016FY2025

Free cash flow

IDR 39.00bn

FY2016FY2025

Shareholders' equity

IDR 315.42bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueIDR 4.11trnIDR 3.92trnIDR 3.36trnIDR 3.20trnIDR 2.99trnIDR 2.64trnIDR 2.73trnIDR 2.38trnIDR 2.11trnIDR 1.97trn
Gross profitIDR 338.96bnIDR 334.38bnIDR 289.82bnIDR 269.63bnIDR 241.75bnIDR 221.69bnIDR 228.76bnIDR 210.16bnIDR 179.60bnIDR 169.24bn
Operating incomeIDR 129.60bnIDR 96.43bnIDR 105.40bnIDR 73.96bnIDR 57.74bnIDR 52.86bnIDR 64.77bnIDR 63.11bnIDR 49.32bnIDR 47.88bn
Net incomeIDR 38.47bnIDR 16.91bnIDR 33.09bnIDR 24.46bnIDR 9.57bnIDR 2.80bnIDR 7.88bnIDR 19.44bnIDR 14.18bnIDR 11.11bn
Diluted earnings per share30.2013.2825.9719.207.512.206.1915.2615.9814.97

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsIDR 1.96trnIDR 1.77trnIDR 1.64trnIDR 1.40trnIDR 1.21trnIDR 1.16trnIDR 1.23trnIDR 1.19trnIDR 938.01bnIDR 733.44bn
Cash and short-term investmentsIDR 62.84bnIDR 53.47bnIDR 58.90bnIDR 25.67bnIDR 47.36bnIDR 48.05bnIDR 29.49bnIDR 37.69bnIDR 56.46bnIDR 33.56bn
Total liabilitiesIDR 1.65trnIDR 1.49trnIDR 1.36trnIDR 1.14trnIDR 969.41bnIDR 935.63bnIDR 995.41bnIDR 960.78bnIDR 725.39bnIDR 590.17bn
DebtIDR 809.28bnIDR 846.52bnIDR 710.34bnIDR 568.06bnIDR 456.95bnIDR 385.42bnIDR 492.69bnIDR 421.00bnIDR 344.47bnIDR 296.19bn
Shareholders' equityIDR 315.42bnIDR 282.52bnIDR 277.72bnIDR 258.91bnIDR 236.98bnIDR 229.20bnIDR 235.44bnIDR 232.11bnIDR 212.61bnIDR 143.28bn
Shares outstanding1,274m1,274m1,274m1,274m1,274m1,274m1,274m1,274m887m742m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsIDR 88.10bn−IDR 125.45bn−IDR 91.65bnIDR 41.00bn−IDR 18.18bnIDR 71.69bn−IDR 25.26bnIDR 4.72bnIDR 4.46bn−IDR 26.99bn
Capital spending−IDR 49.10bn−IDR 14.16bn−IDR 21.52bn−IDR 14.68bn−IDR 4.47bn−IDR 3.81bn−IDR 10.82bn−IDR 6.35bn−IDR 6.61bn−IDR 8.45bn
Free cash flowIDR 39.00bn−IDR 139.61bn−IDR 113.17bnIDR 26.32bn−IDR 22.65bnIDR 67.88bn−IDR 36.08bn−IDR 1.63bn−IDR 2.16bn−IDR 35.44bn
Dividends paid−IDR 2.54bn−IDR 3.19bn−IDR 2.55bn−IDR 1.27bn−IDR 637.0m−IDR 1.27bn−IDR 3.82bn−IDR 2.55bn−IDR 1.46bn−IDR 2.18bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueIDR 1.11trnIDR 1.02trnIDR 1.11trnIDR 1.06trnIDR 962.50bnIDR 980.19bnIDR 992.75bnIDR 983.83bn
Gross profitIDR 90.48bnIDR 87.64bnIDR 105.48bnIDR 85.49bnIDR 82.83bnIDR 88.57bnIDR 82.18bnIDR 79.24bn
Operating incomeIDR 32.38bnIDR 28.19bnIDR 49.72bnIDR 24.71bnIDR 24.15bnIDR 31.25bnIDR 16.58bnIDR 25.65bn
Net incomeIDR 9.46bnIDR 10.10bnIDR 18.08bnIDR 3.64bnIDR 6.41bnIDR 10.33bn−IDR 3.57bnIDR 5.14bn
Diluted earnings per share7.427.9314.192.865.038.11-2.804.03
Cash from operations−IDR 101.39bn−IDR 60.98bnIDR 71.80bn−IDR 35.32bn−IDR 18.67bnIDR 70.29bnIDR 23.21bn−IDR 1.41bn
Capital spending−IDR 992.0m−IDR 1.95bn−IDR 18.41bn−IDR 27.96bn−IDR 1.64bn−IDR 1.09bn−IDR 9.49bn−IDR 1.11bn
Free cash flow−IDR 102.38bn−IDR 62.94bnIDR 53.39bn−IDR 63.29bn−IDR 20.31bnIDR 69.20bnIDR 13.72bn−IDR 2.53bn
Total assetsIDR 2.10trnIDR 2.02trnIDR 1.96trnIDR 1.90trnIDR 1.89trnIDR 1.80trnIDR 1.77trnIDR 1.78trn
Cash and short-term investmentsIDR 33.78bnIDR 39.84bnIDR 62.84bnIDR 37.82bnIDR 45.85bnIDR 59.24bnIDR 53.47bnIDR 8.29bn
DebtIDR 947.74bnIDR 849.47bnIDR 809.80bnIDR 848.25bnIDR 793.23bnIDR 789.25bnIDR 846.52bnIDR 820.63bn
Shareholders' equityIDR 331.16bnIDR 325.53bnIDR 315.42bnIDR 300.35bnIDR 296.71bnIDR 292.85bnIDR 282.52bnIDR 295.05bn

Financial ratios

Data as of 4 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin8.2%8.5%8.6%8.4%8.1%8.4%
Operating margin3.2%2.5%3.1%2.3%1.9%2.0%
Net margin0.9%0.4%1.0%0.8%0.3%0.1%
Return on equity12.2%6.0%11.9%9.4%4.0%1.2%
Return on assets2.0%1.0%2.0%1.7%0.8%0.2%
Free cash flow yield55.2%-44.8%-28.2%22.4%-5.5%30.4%
Revenue growth4.9%16.5%5.1%7.1%13.1%-3.0%
Earnings growth127.4%-48.9%35.2%155.6%241.3%-64.4%
Current ratio1.10x1.11x1.12x1.13x1.14x1.14x
Debt to equity2.57x3.00x2.55x2.19x2.17x1.96x
Equity ratio16.1%15.9%16.9%18.5%19.6%19.7%
Interest coverage2.00x1.40x1.83x1.92x1.45x1.17x
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.7%9.2%9.2%
Operating income20.6%19.6%11.8%
Net income16.3%68.8%12.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin8.4%8.4%8.4%8.5%
Operating margin2.8%2.8%2.6%2.5%
Net margin0.7%0.8%0.6%0.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings5.19.96.117.318.147.315.46.26.96.2
Price to sales0.10.00.10.10.10.10.00.10.10.0

Dividends and splits

Per share, in the currency the company pays

Paid for 10 years. Last went ex-dividend on 12 Jun 2025.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year2.002.502.001.000.501.003.002.00
  • 5-for-1 split · 3 Sept 2001
  • 2-for-1 split · 3 Feb 1999
  • 4-for-3 split · 14 Jan 1999
  • 3-for-2 split · 4 Jan 1994

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.